MedTrace Logo

Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery

NCT01587781 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2022-03-17

No results posted yet for this study

Summary

This study is about a drug called enoxaparin which is used to prevent or treat blood clots. There are no studies about the use of this drug in obese adolescents and yet the investigators use it to prevent clots when they have surgery at Children's National for weight loss. The investigators hypothesis is that the obesity leads to increased kidney size and faster drug clearance. Therefore the investigators think they might be underdosing these adolescents. This study will check the drug levels at different points after the drug dose to see whether the investigators are achieving the expected levels for prevention of clots.

Conditions

Sponsors & Collaborators

  • Janelle Vaughns

    lead OTHER

Principal Investigators

  • Janelle Vaughns, MD · Children's National Research Institute

Eligibility

Min Age
12 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01587781 on ClinicalTrials.gov